Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2025 ∙ Kong, F. Cai, L. Zhang, J. Zhu, H. Peng, Z. Zheng, J. Zheng, Y. Fang, H.

Comparative Analysis of Health Economic Evaluations for Different Influenza Vaccines and Vaccination Strategies in China: A Systematic Review

  • Western Pacific
  • China
  • All age groups
  • Pregnant women
  • Influenza
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Jeong, M. Jang, I.

Comparative effectiveness and immunogenicity of single-dose and multi-dose human papillomavirus vaccination: a systematic review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Wang, X. Pahwa, A. Bausch-Jurken, M. T. Chitkara, A. Sharma, P. Malmenas, M. Vats, S. Whitfield, M. G. Lai, K. Z. H. Dasari, P. Gupta, R. Nassim, M. Van de Velde, N. Green, N. Beck, E.

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Fahrbach, K. Cichewicz, A. Chu, H. Di Fusco, M. Burnett, H. Volkman, H. R. Akin-Fajiye, M. Mendoza, C. F. Cappelleri, J. C.

Comparative effectiveness of Omicron XBB 1.5-adapted COVID-19 vaccines: a systematic literature review and network meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Syed, A. A. Eqbal, F. Shamsi, H. R. Syed, A. R. S. Zakir, S. J. Fawzy, M. Khan, K. S.

Comparative effectiveness of three common SARS-COV-2 vaccines: A network meta-analysis of randomized trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Rai, S. Tripathi, S.

Comparative efficacy of leading COVID-19 vaccines: A netwometa-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Ma, K. Christensen, M. Turnbull, M.

Comparative synthesis of sociocultural and political influences (SPIs) on COVID-19 vaccine hesitancy: an interdisciplinary systematic review

  • Adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Santos, S. A. D. Sato, M. Y. Basilio, P. H. G. Pereira, M. E. Juliao, R. C. Arruda, N. D. C. Silva, D. P. D. Oliveira, C. S. Costa-Junior, V. H. D. S. Guiloski, I. C.

Comparison between the safety of the HPV vaccine versus placebo: a systematic review and meta-analysis of randomized clinical trials

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Goldsmith, J. J. Tavlian, S. Vu, C. Regan, A. K. Campbell, P. T. Sullivan, S. G.

Comparison of 2 Doses vs 1 Dose in the First Season Children Are Vaccinated Against Influenza: A Systematic Review and Meta-Analysis

  • Newborn
  • Children
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Abo Zeid, M. Elrosasy, A. Farho, M. A. Rifai, M. Aboelkhier, M. M. Elkhrashy, M. N. Zabady, A. H. Zaki, M. S. A. Hamed, E. M. Dawood, S. A. Abuzaid, Y.

Comparison of safety and immunogenicity between Healive, Havrix and live attenuated Hepatitis A vaccines in pediatric population: a systematic review with meta-analysis

  • All age groups
  • Hepatitis A
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...